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Shock Waves in Patients with Renal Stones
Jong Yeon Lee, Young Tae Moon
Department of Urology, Chung-Ang University College of Medicine, Seoul, Korea
Purpose: Many studies have been carried out to increase the success rate of shock wave 
lithotripsy (SWL) and to reduce renal injury. We investigated the success rate after 
one session as well as urine N-acetyl-β-d-glucosaminidase (NAG) levels for the evalua-
tion of renal injury according to shock wave frequency and pretreatment with low-en-
ergy shock waves during SWL.
Materials and Methods: The study targeted 48 patients with renal stones who had un-
dergone SWL. Patients were sequentially allocated into four groups according to shock 
wave frequency (60 or 120 shocks/min) and whether pretreatment had occurred. We 
documented total SWL operating number, success rate after first SWL, urine NAG, 
compliance, and the total cost for each patient. 
Results: There were 32 males and 16 females with an average age of 51.6 years. The 
average stone size was 7.06 mm, and there was no significant difference in stone size 
between the groups. The data showed that patients treated with a frequency of 60 
shocks/min had a lower mean number of SWL sessions, 1.36 sessions for 60 shocks/min 
and 2.0 sessions for 120 shocks/min, respectively, which was statistically significant 
(p＜0.05). When comparing NAG/creatinin ratios before and after SWL between those 
with and without pretreatment, there was no significant difference according to pre-
treatment (p=0.406).
Conclusions: SWL treatment at a frequency of 60 shocks/min yielded better outcomes, 
such as a lower number of SWL sessions, and had an increased success rate compared 
with SWL at 120 shocks/min. On the other hand, pretreatment did not impact renal 
injury. Therefore, SWL treatment at a frequency of 60 shocks/min could improve treat-
ment efficacy more than that for SWL at 120 shocks/min.
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INTRODUCTION
Since its introduction in the early 1980s, extracorporeal 
shock wave lithotripsy (ESWL) has been the most popular 
method for urinary stone treatment because it is relatively 
noninvasive, has few complications, and has a high success 
rate [1]. In particular, it has been the method of choice for 
treatment of renal stones ≤20 mm [2]. 
Although shock wave lithotripsy (SWL) is noninvasive, 
shock waves can cause renal injury in an area of intra-
parenchymal hemorrhage in the line of the blast path. 
Complications such as subcapsular and retroperitoneal 
hemorrhage have been well-recognized, and long-term is-
sues such as hypertension, particularly in older patients, 
continue to be of concern. These complications have arisen 
from damage to the renal parenchyma, which is directly re-
lated to the number of shock waves, maximum kV ad-
ministered [3], and the rate of voltage escalation during 
SWL treatment [4]. If slower shock wave rates lead to clin-
ically improved stone fragmentation, patients could be at 
decreased risk for these side effects and be spared addi-
tional SWL or more invasive surgical treatments. To gen-Korean J Urol 2011;52:776-781
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erate better results and fewer complications, many meth-
ods have been introduced, including elevation of shock 
wave power (voltage stepping), the use of lower frequency 
shock waves, and pretreatment with low-energy shock 
waves while performing SWL [4-6]. 
Greenstein first suggested improvements in stone frag-
mentation with a reduction in the frequency of shocks per 
minute, and following this report, many studies both in vi-
tro and in vivo have reported the advantage of low-fre-
quency shock waves [5,7,8]. Furthermore, Willis et al re-
ported that renal injury could be reduced by pretreatment 
with low-energy shock waves during SWL [9].
N-Acetyl-β-d-glucosaminidase (NAG) is a lysosomal en-
zyme that is abundantly present in the cells of the proximal 
tubule and that has been considered a very sensitive mark-
er of renal tubular impairment [10-12]. Also, the urine 
NAG/creatinine (Cr) ratio has been shown to increase after 
SWL and to remain high for 4 days after, requiring 4 weeks 
to normalize [13].
Many studies on SWL have used the Dornier Compact 
Delta lithotripter, LithoTron, and the Lithotripter S. We 
hypothesized that lower frequency shock waves and pre-
treatment with low-energy shock waves during SWL would 
generate better results and fewer complications related to 
SWL in renal stone patients being treated with a Sonolith 
Praktis (EDAP Technomed, France) in our hospital. In ad-
dition, we investigated the success rate after one session 
as well as urine NAG levels for the evaluation of renal in-
jury according to shock wave frequency and pretreatment 
with low-energy shock waves during SWL, respectively.
MATERIALS AND METHODS
In this case-controlled study, we prospectively audited con-
secutive adult patients who had undergone SWL for renal 
stones ≤15 mm in size from December 2010 to May 2011 
in our hospital. We selected 48 patients who were diag-
nosed with renal stones and received SWL as the first 
treatment. These patients were sequentially allocated and 
assessed according to treatment success as measured by 
the stone-free rate and the degree of renal injury. We ex-
cluded patients with severe hydronephrosis, ureteral stric-
ture, neurogenic bladder, multiple renal stones, or calyceal 
diverticular stones and those lacking follow-up. The diag-
nosis of renal stones was done with KUB, intravenous pye-
lography (IVP), or computed tomography (CT). Renal stone 
size was measured by the largest diameter following pa-
tient examination. We performed KUB for radio-opaque 
stones as a follow-up for renal stones at 2 week intervals.
Patients were sequentially treated by four methods. The 
first involved having been pretreated with low-energy 
shock waves during ESWL and having received 2,000 to 
3,000 shocks at a rate of 60 shocks/min. The second method 
involved not having been subjected to pretreatment with 
low-energy shock waves and having received 2,000 to 3,000 
shocks at a rate of 60 shocks/min. The third method in-
volved having been subjected to pretreatment with low-en-
ergy shock waves and having received 2,000 to 3,000 shocks 
at a rate of 120 shocks/min. The fourth method involved not 
having been subjected to pretreatment with low-energy 
shock waves and having received 2,000 to 3,000 shocks at 
a rate of 120 shocks/min. 
Patients were allocated into four groups for this study. 
Group I had received 2,000 to 3,000 shocks at a rate of 60 
shocks/min, and group II had received 2,000 to 3,000 shocks 
at a rate of 120 shocks/min. All SWL was performed by in-
dividuals whom had performed at least 2,000 shocks. 
Furthermore, SWL was terminated when the treating ur-
ologist agreed that the stone appeared to be fragmented or 
when 3,000 shocks had been administered. Group III had 
been subjected to pretreatment with low-energy shock 
waves during SWL, and group IV had not been subjected 
to pretreatment with low-energy shock waves during SWL. 
All SWL was done by using the Sonolith Praktis (EDAP 
Technomed, France) with the patient in a supine position. 
A session of SWL was set to 2,000 to 3,000 shocks. For pre-
treatment with low-energy shock waves, patients received 
500 shocks of a 12 kV shock wave followed by 3 minutes of 
waiting time. The power of the shock wave was increased 
by 12 kV to a maximum of 24 kV [9]. In the non-pretreat-
ment with low-energy shock waves group, the potency was 
increased from 12 kV to 24 kV. All procedures were per-
formed under intravenous injection (IV) of ketorolac tro-
methamine 30 mg/ml to control pain. In cases of failure re-
garding pain control, we injected pethidine HCL 50 mg IV. 
After treatment, we advised all patients regarding oral hy-
dration and exercise and checked for complications includ-
ing pain, infection, hematuria, and the presence of D-J 
stenting. 
Success was defined as asymptomatic status, stone-free 
status, or detection of asymptomatic residual stone frag-
ments ≤3 mm in size [14]. To confirm success and excretion 
of renal stone fragments (stone-free status) after SWL, pa-
tients were assessed with KUB after 2 weeks. For non-
visible stones or minimal fragments on KUB, we confirmed 
success by noncontrast CT (NCCT) [15]. 
To investigate the influence of shock waves on kidney in-
jury, each patient was evaluated with a complete blood cell 
count (CBC), blood urea nitrogen (BUN), creatinine, and 
urine NAG before lithotripsy and at 3 days after SWL. 
Because of differences in renal excretion function, urine 
NAG was calibrated by using urine Cr levels. 
We compared groups I and II to evaluate the success rate 
of shock wave frequency variation. A comparison of groups 
III and IV was done to evaluate renal injury following pre-
treatment with low-energy shock waves.
We documented gender, age, stone size, stone location, 
number of sessions up to stone-free status, pain scale, Cr, 
NAG, NAG/Cr ratio, and total cost in each patient. Data 
were analyzed via a Student's t-test, ANOVA, and 
chi-square test using SPSS ver. 17.0 (SPSS Inc., Chicago, 
IL, USA). Statistical significance was set at a level of 5%.Korean J Urol 2011;52:776-781
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TABLE 1. ESWL treatment, outcomes, and costs according to shock wave frequency
60 shocks/min
(group I)
120 shocks/min
(group II)
p-value
No. of patients
Age (yr, SD)
Male:Female
Stone side (Lt:Rt)
Stone location
    Renal stone:Pelvis stone
Stone size (mm, SD)
No. of ESWL sessions to success (SD)
Total no. of shock waves (SD) 
Treatment success after 1st ESWL (%)
Analgesia requirement
Pain scale (VAS) (0-10)
25
52.4 (±14.2)
17:8
  12:13
    9:16
   6.6 (±0.5)
   1.36 (±0.11)
3,358 (±271)
64.0
40.0
    0.63
23
50.9 (±15.2)
15:8
    9:13
    9:14
   7.6 (±5.2)
   2.00 (±0.21)
4,924 (±517)
34.8
34.8
  0.6
0.728
0.838
0.536
0.823
0.149
0.008
0.008
0.044
0.709
0.523
Group I had received 2,000-3,000 shocks at a rate of 60 shocks/min, and group II had received 2,000-3,000 shocks at a rate of 120 
shocks/min, EWSL, extracorporeal shock wave lithotripsy, Lt: left, Rt: right, VAS: visual analogue scale
FIG. 1. (A) Treatment outcomes according to frequency (p=0.044). (B) N-Acetyl-β-d-glucosaminidase (NAG)/creatinine (Cr) levels 
according to pretreatment (p=0.406). I: 60 shocks/min (group I), II: 120 shocks/min (group II), III: pretreatment (group III), IV: 
non-pretreatment (group IV). 
RESULTS
Of patients who had SWL treatment, we targeted 48. Their 
average age was 51.6 years, and patients were allocated in-
to four groups as follows: 60 shocks/min, 120 shocks/min, 
and the presence or absence of low-voltage pretreatment 
shock waves. There were 32 males and 16 females, and an 
average stone size of 7.06 mm. The mean number of SWL 
sessions to success was 1.66.
We performed a comparative analysis between the 60 
shocks/min (group I) and 120 shocks/min (group II) groups 
to determine success rate after lithotripsy. Stone size, 
stone side, and stone location showed no significant differ-
ences between the two groups. The mean number of SWL 
sessions was 1.36 at a frequency of 60 shocks/min and 2.0 
at a frequency of 120 shocks/min, a statistically significant 
difference (p=0.008). With respect to the success rate after 
the first treatment, 64.0% of patients were successfully 
treated in the 60 shocks/min group and 34.8% of patients 
were successfully treated in the 120 shocks/min group (p
＜0.05) (Table 1 and Fig. 1).
Results according to NAG/Cr levels after SWL treatment 
were assessed to investigate renal injury. Stone size, stone 
side, and stone location showed no significant differences 
between the two groups. When comparing NAG/Cr levels 
before SWL treatment with or without pretreatment with 
low-energy shock waves, groups III and IV exhibited no 
statistical differences. The data showed that NAG/Cr lev-
els were, respectively, 12.61 (pretreatment with low-en-
ergy shock waves) and 10.53 (non-pretreatment with 
low-energy shock waves) after SWL treatment, a difference 
that failed to achieve statistical significance (p=0.406) 
(Table 2 and Fig. 1).
With regard to post-SWL complications, gross hema-
turia was frequent in 31 patients (65%), intolerable pain 
with ketorolac tromethamine 30 mg/ml in 18, and urinary Korean J Urol 2011;52:776-781
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TABLE 2. ESWL treatment, outcomes, and costs according to pretreatment with low-energy shock waves
Pretreatment
(group III)
Non-pretreatment
(group IV)
p-value
No. of patients
Age (yr, SD)
Male:Female
Stone side (Lt:Rt)
Stone location
    Renal stone:Pelvis stone
Stone size (mm, SD)
No. of ESWL sessions to success (SD)
Total no. of shock waves (SD)
Pre-ESWL Cr (gm/l, SD)
Post-ESWL Cr (gm/l, SD) 3 days later
Pre-NAG/Cr (SD)
Post-NAG/Cr (SD) 3 days later
24
51.9 (±3.3)
13:11
13:11
10:14
  7.74 (±2.38)
  1.79 (±0.97)
 4,451 (±2388)
  1.09 (±0.11)
  1.05 (±0.08)
10.12 (±3.20)
12.61 (±2.00)
24
51.4 (±2.7)
15:9
    8:16
    8:16
  6.54 (±2.43)
  1.54 (±0.72)
 3,829 (±1772)
  1.04 (±0.07)
  1.07 (±0.06)
16.53 (±9.36)
10.53 (±1.40)
0.899
0.137
0.141
0.267
0.120
0.318
0.318
0.883
0.738
0.525
0.406
Group III had been subjected to pretreatment with low-energy shock waves during SWL, and group IV had not been subjected to pretreat-
ment with low-energy shock waves during SWL, Lt: left, Rt: right, EWSL: extracorporeal shock wave lithotripsy, NAG: N-acetyl-β-d-glu-
cosaminidase, Cr: creatinine
tract infection in another. Furthermore, D-J stenting as an 
auxiliary procedure was required in 3 (6%). There were no 
significant differences between the groups.
DISCUSSION
Since its introduction in the 1980s, SWL has been used as 
the most popular method for urinary stone treatment be-
cause of its relatively high success rate and stability [1]. 
According to recent improvements in imaging devices, re-
nal stone incidence has increased and the role of SWL has 
grown in importance. Moreover, a need has arisen for safer 
and more effective results with respect to SWL.
Recently, many studies have been conducted to improve 
the success rate through the use of effective analgesics, al-
pha-1 adrenaline receptor antagonists, and a reduction in 
the frequency of shock waves when performing SWL [4-6]. 
A suitable number and frequency of shock waves for uri-
nary stones has yet to be defined; however, according to a 
recent study, high-frequency shock waves can reduce stone 
fragmentation during lithotripsy. Yilmaz et al in a clinical 
setting, allocated patients into three groups: 60, 90, and 
120 shocks/minute and found that success rates were sim-
ilar between the groups receiving 60 and 90 shocks/minute 
and that both were higher than in the group receiving 120 
shocks/minute [8]. Semins et al reported that when com-
paring 60 and 120 shocks/min, there was significant im-
provement in success rates [16]. Furthermore, Koo et al 
showed that 70 impulses/min compared with 100 sig-
nificantly improved the success rate and reduced total cost 
[14]. 
According to our results, 60 shocks/min (group I) com-
pared with 120 (group II) showed a significant improve-
ment in the success rate. Furthermore, there were sig-
nificant differences between 60 and 120 shocks/min with 
respect to the total number of SWL sessions and total cost. 
These results relate to the ability of low-frequency shock 
waves to improve the stone success rate and thus sig-
nificantly affect the effective excretion of the renal stone. 
Additionally, the frequency of complications did not show 
any significant difference between the groups.
Many studies have supported the assertion that slower 
shock wave rates may improve stone comminution [17,18]. 
The mechanism for the increased efficiency of SWL at 60 
shocks/min may be related to decreased acoustic im-
pedance mismatch, improved cavitation bubble pro-
duction on the stone surface, or improved bubble dynamics 
due to water and gas content surrounding the stone [19]. 
The most likely explanation has been related to the impact 
of the shock wave rate on cavitation bubbles. Although cav-
itation bubbles in contact with the stone surface contribute 
to stone fragmentation, more remote cavitation bubbles 
may act as a barrier to efficient shock wave energy 
transmission. Therefore, slowing the shock wave rate may 
allow this barrier of bubbles to dissipate, allowing in-
creased gas content in the fluid medium adjacent to the 
stone, and support better cluster bubble dynamics on the 
stone surface to promote superior fragmentation.
Renal complications can be subdivided into early effects 
on kidney anatomy that lead to hematuria and hematoma 
formation and late complications that affect kidney func-
tion and cause systemic hypertension. Histopathological 
examination of human and animal kidneys has shown en-
dothelial cell damage to midsized arteries, veins, and glo-
merular capillaries immediately after SWL [20,21]. 
Thin-walled arcuate veins in the corticomedullary junction 
have been shown to be especially vulnerable to shock wave 
exposure and are related to hematuria and hematoma [20].
SWL-induced acute renal damage may also result in se-
vere injury to the nephron, microvasculature, and the sur-
rounding interstitium [22]; renal tubules and vessels have 
been demonstrated to be more vulnerable than renal blood Korean J Urol 2011;52:776-781
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flow to discharge energy [23]. These injuries may be related 
to the long-term effects of SWL on renal function.
In an in vivo study, Wills et al reported that 500 pretreat-
ments with low-energy shock waves reduced renal injury. 
It has been suggested that the low-energy shock waves 
cause vasoconstriction of vessels into the kidney and reduc-
tion of blood flow, resulting in an impact on the reduction 
of hematoma and renal injury during SWL [9]. 
In our study, we investigated NAG/Cr levels, Cr, and 
NAG released into urine during the early stages of renal 
cell injury in order to assess renal injury. As the final out-
come, we did not find any significant difference in NAG/Cr 
levels between patients who had been pretreated with 
low-energy shock waves (group III) and those who had not 
been pretreated (group IV). This indicated that pretreat-
ment before SWL does not affect renal injury. Our results 
showed that group IV had a lower NAG/Cr level than did 
group III. 
Our study was not related to renal injury and pretreat-
ment with low-energy shock waves; however, our study in-
cluded a small number of patients, and NAG activity was 
high during the first 24 hours after lithotripsy in another 
study [24]. Additionally, if we had measured the number 
of patients and evaluated other renal enzymes, we may 
have gotten different results.
We first compared the success rate and renal injury si-
multaneously in relation to lower frequency shock waves 
and pretreatment with low-energy shock waves. We found 
that low-frequency shock waves improved the stone suc-
cess rate and thus significantly affected the effective ex-
cretion of renal stones. In this study, no group exhibited an 
association between renal injury according to pretreat-
ment with low-energy shock waves during ESWL; how-
ever, the success rates of low-frequency shock waves in-
creased and the total ESWL sessions required decreased. 
Therefore, low-frequency shock waves may be helpful in 
preventing long-term complications according to reduced 
total ESWL numbers. 
A limitation of this study was that we examined only 48 
patients from a single center. To confirm our findings, fur-
ther study should be carried out on a large scale. Such study 
should assess how variations in shock wave strength and 
pretreatment with low-energy shock waves affect the suc-
cess rate and renal injury. 
CONCLUSIONS
Shock wave lithotripsy treatment at 60 shocks/min yielded 
better outcomes of lower SWL sessions and increased suc-
cess rate compared with treatment at a frequency of 120 
shocks/min. In contrast, pretreatment with low-energy 
shock waves did not significantly impact renal injury. 
Therefore, SWL treatment at a frequency of 60 shocks/min 
could improve the treatment efficacy of the commonly used 
120 shocks/min procedure. Further assessment of the rela-
tionship between pretreatment with low-energy shock 
waves and reduction in renal injury is suggested for further 
research.
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